This paper is in the following e-collection/theme issue:

#xEndocrinology (4) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (156) Diabetes (187) Diabetes Self-Management (484) Obesity (75) Innovative Methods in Public Health and Surveillance (332) Decision Support for Health Professionals (1185)

Published on in Vol 5 (2024)

Preprints (earlier versions) of this paper are available at https://www.medrxiv.org/content/10.1101/2023.11.19.23298750v1, first published .
Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis

Authors of this article:

Tigran Makunts1 Author Orcid Image ;   Haroutyun Joulfayan2 Author Orcid Image ;   Ruben Abagyan1 Author Orcid Image
Article Authors Cited by (4) Tweetations (8) Metrics

Journals

  1. Makunts T, Joulfayan H, Abagyan R. Authors’ Response to Peer Reviews of “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”. JMIRx Med 2024;5:e58273 View
  2. . Peer Review for “Thyroid Hyperplasia and Neoplasm Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists in the Food and Drug Administration Adverse Event Reporting System: Retrospective Analysis”. JMIRx Med 2024;5:e59120 View
  3. Torbahn G, Lischka J, Brown T, Ells L, Kelly A, Wabitsch M, Weghuber D. Anti‐Obesity Medication in the Management of Children and Adolescents With Obesity: Recent Developments and Research Gaps. Clinical Endocrinology 2024 View
  4. Kelly C, Sipos J. Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists. The Journal of Clinical Endocrinology & Metabolism 2024 View